Quantitative and clinical impact of MRI-based attenuation correction methods in [18F]FDG evaluation of dementia
Tóm tắt
Positron emission tomography/magnetic resonance imaging (PET/MRI) is a promising diagnostic imaging tool for the diagnosis of dementia, as PET can add complementary information to the routine imaging examination with MRI. The purpose of this study was to evaluate the influence of MRI-based attenuation correction (MRAC) on diagnostic assessment of dementia with [18F]FDG PET. Quantitative differences in both [18F]FDG uptake and z-scores were calculated for three clinically available (DixonNoBone, DixonBone, UTE) and two research MRAC methods (UCL, DeepUTE) compared to CT-based AC (CTAC). Furthermore, diagnoses based on visual evaluations were made by three nuclear medicine physicians and one neuroradiologist (PETCT, PETDeepUTE, PETDixonBone, PETUTE, PETCT + MRI, PETDixonBone + MRI). In addition, pons and cerebellum were compared as reference regions for normalization. The mean absolute difference in z-scores were smallest between MRAC and CTAC with cerebellum as reference region: 0.15 ± 0.11 σ (DeepUTE), 0.15 ± 0.12 σ (UCL), 0.23 ± 0.20 σ (DixonBone), 0.32 ± 0.28 σ (DixonNoBone), and 0.54 ± 0.40 σ (UTE). In the visual evaluation, the diagnoses agreed with PETCT in 74% (PETDeepUTE), 67% (PETDixonBone), and 70% (PETUTE) of the patients, while PETCT + MRI agreed with PETDixonBone + MRI in 89% of the patients. The MRAC research methods performed close to that of CTAC in the quantitative evaluation of [18F]FDG uptake and z-scores. Among the clinically implemented MRAC methods, DixonBone should be preferred for diagnostic assessment of dementia with [18F]FDG PET/MRI. However, as artifacts occur in DixonBone attenuation maps, they must be visually inspected to assure proper quantification.
Tài liệu tham khảo
Barthel H, Schroeter ML, Hoffmann KT, Sabri O. PET/MR in dementia and other neurodegenerative diseases. Semin Nucl Med. 2015;45(3):224–33.
Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics. 2014;34(3):684–701.
Dukart J, Mueller K, Horstmann A, Barthel H, Moller HE, Villringer A, et al. Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PLoS One. 2011;6(3):e18111.
Singh TD, Josephs KA, Machulda MM, Drubach DA, Apostolova LG, Lowe VJ, et al. Clinical, FDG and amyloid PET imaging in posterior cortical atrophy. Journal of neurology. 2015;262(6):1483–92.
Ladefoged CN, Law I, Anazodo U, Lawrence KS, Izquierdo-Garcia D, Catana C, et al. A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients. NeuroImage. 2016.
Cabello J, Lukas M, Rota Kops E, Ribeiro A, Shah NJ, Yakushev I, et al. Comparison between MRI-based attenuation correction methods for brain PET in dementia patients. Eur J N ucl Med Mol Imaging. 2016;43(12):2190–200.
Werner P, Rullmann M, Bresch A, Tiepolt S, Jochimsen T, Lobsien D, et al. Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET/MRI. EJNMMI Res. 2016;6(1):47.
Franceschi AM, Abballe V, Raad RA, Nelson A, Jackson K, Babb J, et al. Visual detection of regional brain hypometabolism in cognitively impaired patients is independent of positron emission tomography-magnetic resonance attenuation correction method. World J Nucl Med. 2018;17(3):188–94.
Paulus DH, Quick HH, Geppert C, Fenchel M, Zhan Y, Hermosillo G, et al. Whole-body PET/MR imaging: quantitative evaluation of a novel model-based MR attenuation correction method including bone. Journal of nuclear medicine : official publication. Soc Nucl Med. 2015;56(7):1061–6.
Koesters T, Friedman KP, Fenchel M, Zhan Y, Hermosillo G, Babb J, et al. Dixon sequence with Superimposed model-based bone compartment provides highly accurate PET/MR attenuation correction of the brain. J Nucl Med. 2016;57(6):918–24.
Burgos N, Cardoso MJ, Thielemans K, Modat M, Pedemonte S, Dickson J, et al. Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies. IEEE Trans Med Imaging. 2014;33(12):2332–41.
NiftyWeb [Available from: http://cmictig.cs.ucl.ac.uk/niftyweb/.
Prados Carrasco F, Cardoso MJ, Burgos N, Wheeler-Kingshott C, Ourselin S, editors. NiftyWeb: web based platform for image processing on the cloud2016: International Society for Magnetic Resonance in Medicine (ISMRM).
Carney JP, Townsend DW, Rappoport V, Bendriem B. Method for transforming CT images for attenuation correction in PET/CT imaging. Med Phys. 2006;33(4):976–83.
Ladefoged CN, Marner L, Hindsholm A, Law I, Hojgaard L, Andersen FL. Deep learning based attenuation correction of PET/MRI in pediatric brain tumor patients: evaluation in a clinical setting. Front Neuroscience. 2018;12:1005.
Ronneberger O, Fischer P, Brox T, editors. U-Net: convolutional networks for biomedical image segmentation2015; Cham: Springer International Publishing.
Rorden C, Karnath HO, Bonilha L. Improving lesion-symptom mapping. J Cogn Neurosci. 2007;19(7):1081–8.
Klein S, Staring M, Murphy K, Viergever MA, Pluim JP. elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging. 2010;29(1):196–205.
Shamonin DP, Bron EE, Lelieveldt BP, Smits M, Klein S, Staring M. Fast parallel image registration on CPU and GPU for diagnostic classification of Alzheimer's disease. Front Neuroinform. 2013;7:50.
Aliza Medical Imaging & DICOM Viewer [Available from: [email protected].
Della Rosa PA, Cerami C, Gallivanone F, Prestia A, Caroli A, Castiglioni I, et al. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics. 2014;12(4):575–93.
Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, et al. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. Neuroimage Clin. 2014;6:445–54.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.
Hitz S, Habekost C, Furst S, Delso G, Forster S, Ziegler S, et al. Systematic comparison of the performance of integrated whole-body PET/MR imaging to conventional PET/CT for (1)(8)F-FDG brain imaging in patients examined for suspected dementia. Soc Nucl Med. 2014;55(6):923–31.
Yakushev I, Landvogt C, Buchholz HG, Fellgiebel A, Hammers A, Scheurich A, et al. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res. 2008;164(2):143–53.
Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr. 1995;19(4):541–7.
Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med. 1997;38(6):925–8.
Chen Y, An H. Attenuation correction of PET/MR imaging. Magn Reson Imaging Clin N Am. 2017;25(2):245–55.
Greve DN, Salat DH, Bowen SL, Izquierdo-Garcia D, Schultz AP, Catana C, et al. Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging. NeuroImage. 2016;132:334–43.